Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

Saved in:
Bibliographic Details
Main Authors: San-Miguel, Jesús F. (Author) , Goldschmidt, Hartmut (Author)
Format: Article (Journal)
Language:English
Published: October 2015
In: Haematologica
Year: 2015, Volume: 100, Issue: 10, Pages: 1334-1339
ISSN:1592-8721
DOI:10.3324/haematol.2015.125864
Online Access:Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2015.125864
Get full text
Author Notes:Jesus F. San Miguel, Katja C. Weisel, Kevin W. Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, Anne Banos, Albert Oriol, Laurent Garderet, Michele Cavo, Valentina Ivanova, Adrian Alegre, Joaquin Martinez-Lopez, Christine Chen, Christoph Renner, Nizar Jacques Bahlis, Xin Yu, Terri Teasdale, Lars Sternas, Christian Jacques, Mohamed H. Zaki, and Meletios A. Dimopoulos
Description
Item Description:Gesehen am 08.11.2016
Physical Description:Online Resource
ISSN:1592-8721
DOI:10.3324/haematol.2015.125864